Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;85:269-280

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammond, H. K.
Right arrow Articles by Bloor, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammond, H. K.
Right arrow Articles by Bloor, C. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Circulation, Vol 85, 269-280, Copyright © 1992 by American Heart Association


ARTICLES

Myocardial beta-adrenergic receptor expression and signal transduction after chronic volume-overload hypertrophy and circulatory congestion

HK Hammond, DA Roth, PA Insel, CE Ford, FC White, AS Maisel, MG Ziegler and CM Bloor
VAMC San Diego, CA 92161.

BACKGROUND. The volume-overload, high-output state induced by aortocaval fistula is unique because it is not generally associated with marked abnormalities of contractile function. Thus, changes in beta-adrenergic receptor (beta AR) expression should reflect more directly the influence of neurohumoral adrenergic tone, clarifying the manner in which peripheral (neurohumoral) versus primary myocardial factors are operative in decreased beta AR-dependent signal transduction. METHODS AND RESULTS. We examined the beta-adrenergic receptor-responsive adenylyl cyclase pathway in hearts from pigs subjected to volume-overload hypertrophy with circulatory congestion. Nine pigs underwent initial pharmacological and hemodynamic studies, and, 5 weeks after aortocaval fistula placement, when signs of circulatory congestion were evident, these measurements were repeated. Biochemical analyses of plasma and myocardium from these animals and seven normal animals were compared. Experimental animals showed signs of circulatory congestion (tachypnea, weight gain, pulmonary rales) within 3-4 weeks of fistula placement. Necropsy showed ascites and biventricular cardiac hypertrophy, but no fibrosis or inflammation was present on histological inspection. Heart rate responsiveness to beta AR stimulation was blunted, with ED50, for isoproterenol increased 133% (p less than 0.001) after development of circulatory congestion. Biochemical analyses of the beta AR-responsive adenylyl cyclase pathway showed uniform decreases in beta AR number in right atrium, right ventricle, and left ventricle (36-41% decreases, p less than 0.005). Downregulation was selective for beta 1-receptors, and remaining receptors in the right and left ventricles showed low-affinity agonist binding, suggesting an uncoupling from Gs. All measures of adenylyl cyclase activity were diminished significantly in membrane homogenates from the right atrium (mean reduction, 50 +/- 10%) and left ventricle (mean reduction, 44 +/- 8%) after volume overload. Finally, we found that amounts of cardiac Gs, as measured in reconstitution assays, were decreased in both the right atrium (p less than 0.02) and the left ventricle (p less than 0.01) of volume-overloaded animals but that levels of pertussis toxin substrate were unchanged. CONCLUSIONS. Biochemical findings occurred in the absence of myocardial inflammation or fibrosis and without pharmacological interventions, suggesting that circulatory congestion, with attendant elevation in plasma norepinephrine, may be a sufficient stimulus to induce such changes. The data are compatible with a catecholamine-driven beta AR pathway desensitization. Thus, a primary defect in intrinsic contractile function is not a necessary component for abnormalities of the myocardial beta AR-responsive adenylyl cyclase pathway.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Wang, E. Sentex, H. K. Saini, D. Chapman, and N. S. Dhalla
Upregulation of {beta}-adrenergic receptors in heart failure due to volume overload
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H151 - H159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Wang, E. Sentex, D. Chapman, and N. S. Dhalla
Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H118 - H125.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
N. Daneshtalab, R. Z. Lewanczuk, A. Russell, and F. Jamali
Rheumatoid Arthritis Does Not Reduce the Pharmacodynamic Response to Valsartan
J. Clin. Pharmacol., March 1, 2004; 44(3): 245 - 252.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Eklund, J. Piuhola, J. Komulainen, R. Sormunen, C. Ongvarrasopone, R. Fässler, A. Muona, M. Ilves, H. Ruskoaho, T. E. S. Takala, et al.
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
PNAS, January 23, 2001; (2001) 31444798.
[Abstract] [Full Text]


Home page
CirculationHome page
X. Yu, M. Zhang, K. Kyker, E. Patterson, J. L. Benovic, and D. C. Kem
Ischemic Inactivation of G Protein-Coupled Receptor Kinase and Altered Desensitization of Canine Cardiac {beta}-Adrenergic Receptors
Circulation, November 14, 2000; 102(20): 2535 - 2540.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
F. Di Fusco, S. Hashim, and M. B. Anand-Srivastava
Volume overload cardiac hypertrophy exhibits decreased expression of Gsalpha and not of Gialpha in heart
Am J Physiol Cell Physiol, October 1, 2000; 279(4): C990 - C998.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Xu, S. J. Rials, Y. Wu, T. Liu, R. A. Marinchak, and P. R. Kowey
Effects of Captopril Treatment of Renovascular Hypertension on beta -Adrenergic Modulation of L-Type Ca2+ Current
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 196 - 200.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
N. Dzimiri
Regulation of beta -Adrenoceptor Signaling in Cardiac Function and Disease
Pharmacol. Rev., September 1, 1999; 51(3): 465 - 502.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Anzai, N. C. Lai, M. Gao, and H. K. Hammond
Dissociation between regional dysfunction and beta -adrenergic receptor signaling in heart failure
Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1267 - H1273.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. A. Roth, C. D. White, D. A. Podolin, and R. S. Mazzeo
Alterations in myocardial signal transduction due to aging and chronic dynamic exercise
J Appl Physiol, January 1, 1998; 84(1): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Gando, Y. Hattori, Y. Akaishi, J. Nishihira, and M. Kanno
Impaired Contractile Response to Beta Adrenoceptor Stimulation in Diabetic Rat Hearts: Alterations in Beta Adrenoceptors-G Protein-Adenylate Cyclase System and Phospholamban Phosphorylation
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 475 - 484.
[Abstract] [Full Text]


Home page
CirculationHome page
J. Zhang, C. Toher, M. Erhard, Y. Zhang, K. Ugurbil, R. J. Bache, T. Lange, and D. C. Homans
Relationships Between Myocardial Bioenergetic and Left Ventricular Function in Hearts With Volume-Overload Hypertrophy
Circulation, July 1, 1997; 96(1): 334 - 343.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
L. G. Meggs, H.-e. Huang, B. Li, P. Li, J. Coupet, C. V. Hamby, M. Akanuma, Y. Ishikawa, and P. Anversa
Coronary artery stenosis in rats affects {beta}-adrenergic receptor signaling in myocytes
Cardiovasc Res, January 1, 1997; 33(1): 98 - 109.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. J. Freedman, S. B. Liggett, D. E. Drachman, G. Pei, M. G. Caron, and R. J. Lefkowitz
Phosphorylation and Desensitization of the Human [IMAGE][IMAGE]-Adrenergic Receptor
J. Biol. Chem., July 28, 1995; 270(30): 17953 - 17961.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Eklund, J. Piuhola, J. Komulainen, R. Sormunen, C. Ongvarrasopone, R. Fassler, A. Muona, M. Ilves, H. Ruskoaho, T. E. S. Takala, et al.
Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice
PNAS, January 30, 2001; 98(3): 1194 - 1199.
[Abstract] [Full Text] [PDF]